- Tags: glaucoma
Events
Eyes On Glaucoma 2025 highlights advancements in disease care
Largest virtual glaucoma meeting of the year sees record attendance.
Research
Surprising protective role of estrogen may lower glaucoma risk in women
Age at menopause had a significant effect on RNFL thickness among women.
Pipeline
Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma
New combination therapy involving the prostaglandin analog targets lowering episcleral venous pressure to lower IOP.
Pipeline
SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform
Financing to support upcoming phase 3 trials on the company’s long-term delivery system of bimatoprost for glaucoma and OHT treatment.
Research
Five-year data supports iStent inject as safe and effective
Study finds 72% medication reduction after iStent inject implantation from baseline to last follow-up.
Research
Air pollution exposure leading to more ocular disease cases among adults
Myopic eyes demonstrated increased risk of ocular disease with exposure to air pollution.
Pipeline
Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic
Exploratory Whistler trial reports statistically significant IOP lowering and uveoscleral outflow for NCX 470, an NO-donating bimatoprost formulation.
Products
New World Medical launches upgraded Streamline Surgical System
Single-use, implant-free device offers surgeons improved visualization of key anatomical structures via a new transparent tip.
Research
SpyGlass Pharma reports positive 18-month data on glaucoma sustained delivery system
Presented at ASCRS, new findings show promising visual outcomes and IOP lowering following sustained-release delivery of bimatoprost.
Research
Clinical outcomes support JJV's violet-filtering IOL for glaucoma
New research on the Tecnis Symfony OptiBlue IOL shows promising visual outcomes just one week after implantation post-cataract surgery.
Products
Sight Sciences debuts OMNI Edge Surgical System
Launching during ASCRS, this new hand-held and single-use MIGS device features the company’s patented, higher-capacity viscoelastic delivery TruSync technology.Events
Registration is now open for Eyes On Glaucoma 2025
Largest virtual glaucoma-focused event of the year highlights the latest advancements in disease care and offers up to 4.5 hours of COPE-accredited CE.
Products
FDA clears BVI's laser endoscopic ophthalmic system
Set to debut at AAO later this year, Leos will launch as the only next-gen laser system that lowers IOP by addressing aqueous humor production in a minimally invasive ab interno procedure.
Research
Are uveitis patients at an increased risk for complications post-cataract surgery?
Postoperative complications varied based on the uveitis subtype.
Pipeline
Avisi reports positive 6-month data on VisiPlate aqueous shunt for glaucoma
MIBS device composed of non-fibrotic nanotechnology-based metamaterials lowered OAG patients’ mean IOP by 40%.
Research
Lifestyle habits may benefit cognitive impairment in glaucoma
Mindfulness meditation may help slow the rate of neurocognitive decline.
Business
Eyenovia proposes merger with Betaliq to form glaucoma company
Potential deal would result in a new glaucoma-focused company combining the EyeSol water-free drug delivery tech and Optejet device platform.
Research
Iantrek reports favorable 2-year data on uveoscleral outflow technology for glaucoma
New study details favorable safety profile of the CycloPen System as a bio-interventional platform for OAG patients undergoing combined cataract surgery.
Products
Glaukos and RadiusXR partner with Topcon on VF testing platform
Collaboration involves the launch of RadiusXR’s new wearable vision testing platform, the first tech of its kind to combine visual fields correlated to the clinical standard.
Research